DLTR
64
-2
CSX
48
-2
AKAM
61
5
MU
56
-6
ZTS
19
2
TRV
48
-10
KMI
53
-6
PX
62
6
ORLY
40
-4
XRX
45
4
DVA
49
-3
BAX
50
-3
URBN
70
-4
IR
69
-3
INTU
63
7
PVH
42
-2
ABBV
50
-9
IFF
53
2
AAP
5
-3
PLD
40
-8
DLTR
64
-2
CSX
48
-2
AKAM
61
5
MU
56
-6
ZTS
19
2
TRV
48
-10
KMI
53
-6
PX
62
6
ORLY
40
-4
XRX
45
4
DVA
49
-3
BAX
50
-3
URBN
70
-4
IR
69
-3
INTU
63
7
PVH
42
-2
ABBV
50
-9
IFF
53
2
AAP
5
-3
PLD
40
-8
Financhill
Back

Invesco S&P 500 BuyWrite ETF Vs. Nektar Therapeutics Industry Stock Comparison

Buy
52

PBP
Invesco S&P 500 BuyWrite ETF

Last Price:
$22.98
Seasonality Move:
-1.31%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$44.64
Seasonality Move:
11.58%
Buy
52
Invesco S&P 500 BuyWrite ETF (PBP) is a Buy

Is Invesco S&P 500 BuyWrite ETF a Buy, Sell or Hold?

  • The current Invesco S&P 500 BuyWrite ETF [PBP] share price is $22.97. The Score for PBP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • PBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PBP Stock Price Chart

What is Invesco S&P 500 BuyWrite ETF's stock price today?

  • The Invesco S&P 500 BuyWrite ETF share price today is $22.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PBP is experiencing buying pressure, which is a positive indicator for future bullish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

PBP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.12 Buy
Relative Strength Index (14 RSI): 69.15 Buy
Chaikin Money Flow: 61412 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

PBP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 22.95 Buy
20-day SMA: 22.82 Buy
50-day SMA: 22.6 Buy
200-day SMA: 22.09 Buy
8-day EMA: 22.94 Buy
20-day EMA: 22.84 Buy
50-day EMA: 22.2 Buy
200-day EMA: 14.01 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

Invesco S&P 500 BuyWrite ETF Earnings Growth & PBP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

Invesco S&P 500 BuyWrite ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):